Prosecution Insights
Last updated: September 20, 2026
Application No. 18/458,609

ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE

Non-Final OA §103
Filed
Aug 30, 2023
Priority
Mar 12, 2021 — JP 2021-040544 +2 more
Examiner
EOFF, ANCA
Art Unit
1722
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Fujifilm Holdings Corporation
OA Round
2 (Non-Final)
80%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
1005 granted / 1256 resolved
+15.0% vs TC avg
Moderate +11% lift
Without
With
+10.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
50 currently pending
Career history
1295
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
50.7%
+10.7% vs TC avg
§102
18.7%
-21.3% vs TC avg
§112
20.3%
-19.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1256 resolved cases

Office Action

§103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1 and 4-10 are pending. Claims 2, 3, and 11-20 have been canceled. The foreign priority application No. 2021-040544 filed on March 12, 2021 in Japan has been received and it is acknowledged. The current Office Action introduces new grounds of rejection for claim 4, which recites the same limitations as the canceled claim 12. The canceled claim 12 has been objected to as being dependent on a rejected claim, but allowable if rewritten in independent form (see paragraph 12 of the previous Office Action). Therefore, the Office Action is made non-final. The examiner apologizes for any inconvenience this may cause. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1 and 4-10 are rejected under 35 U.S.C. 103 as being unpatentable over Mertesdorf et al. (EP 0 707 015) in view of Toba (JP H09-328506A, with attached machine translation). With regard to claims 1 and 4, Mertesdorf et al. teach a radiation-sensitive composition comprising a polymer (A) and a compound (B) generating an acid by exposure (par.0031). The polymer (A) may be poly(4-(1-methoxy-1-methylethoxy)styrene/4-(1-methoxy-1-methylethocy)vinylcyclohexane/4-hydroxystyrene/4-vinylcyclohexanol) (par.0067). The 4-(1-methoxy-1-methylethoxy)styrene repeating unit comprises a group of formula -C(CH3)2-O-CH3 which is a group decomposed by an action of an acid to generate a polar group in claim 1 (see par.0111 of the specification of the instant application). The 4-hydroxystyrene repeating unit is a repeating unit of General Formula (A2) in claim 1, wherein R101-R103 are hydrogen atoms, LA is a single bond, ArA is a divalent aromatic group, and k=1. Mertesdorf et al. teach that the compound (B) generating an acid by exposure may be a sulfonium salt (par.0033), but fail to teach the salt of General Formula (2) in claim 1. Toba teaches compounds which may generate an acid upon irradiation without a bad odor (abstract, par.0130-0131). The examples of compounds capable of generating an acid include bis(2-hydroxyethyl)(p-cyanophenacyl)sulfonium tetrafluroborate, bis(2-hydroxyethyl)(m-cyanophenacyl)sulfonium tetrafluroborate, bis(2-hydroxyethyl)(p-methylsulfinylphenacyl)sulfonium tetrafluroborate, bis(2-hydroxyethyl)(p-methylsulfonylphenacyl)sulfonium tetrafluroborate (par.0045), bis(2-hydroxyethyl)(p-cyanophenacyl)sulfonium triflate, bis(2-hydroxyethyl)(m-cyanophenacyl)sulfonium triflate, bis(2-hydroxyethyl)(p-methylsulfinylphenacyl)sulfonium triflate, and bis(2-hydroxyethyl)(p-methylsulfonylphenacyl)sulfonium triflate (par.0057). It would have been obvious to one of ordinary skill in the art before the filing date of the claimed invention to use bis(2-hydroxyethyl)(p-cyanophenacyl)sulfonium tetrafluroborate, bis(2-hydroxyethyl)(m-cyanophenacyl)sulfonium tetrafluroborate, bis(2-hydroxyethyl)(p-methylsulfinylphenacyl)sulfonium tetrafluroborate, bis(2-hydroxyethyl)(p-methylsulfonylphenacyl)sulfonium tetrafluroborate, bis(2-hydroxyethyl)(p-cyanophenacyl)sulfonium triflate, bis(2-hydroxyethyl)(m-cyanophenacyl)sulfonium triflate, bis(2-hydroxyethyl)(p-methylsulfinylphenacyl)sulfonium triflate, or bis(2-hydroxyethyl)(p-methylsulfonylphenacyl)sulfonium triflate as the compound (B) generating an acid by exposure in the radiation-sensitive composition of Mertesdorf et al., in order to avoid bad odors. Bis(2-hydroxyethyl)(p-cyanophenacyl)sulfonium tetrafluroborate, bis(2-hydroxyethyl)(m-cyanophenacyl)sulfonium tetrafluroborate, bis(2-hydroxyethyl)(p-cyanophenacyl)sulfonium triflate, and bis(2-hydroxyethyl)(m-cyanophenacyl)sulfonium triflate are compounds of formula (2) in claim 1, wherein Z- is an anion, m=1, n=2, R2 is a substituted alkyl group, R3 and R4 are hydrogen atoms. Ar is a divalent aromatic ring, l=1, and R1 is a cyano group. Bis(2-hydroxyethyl)(p-methylsulfinylphenacyl)sulfonium tetrafluroborate and bis(2-hydroxyethyl)(p-methylsulfinylphenacyl)sulfonium triflate are compounds of formula (2) in claim 1, wherein Z- is an anion, m=1, n=2, R2 is a substituted alkyl group, R3 and R4 are hydrogen atoms, Ar is a divalent aromatic ring, l=1, and R1 is a *-L-R5, L is -SO-, R5 is a methyl group (monovalent substituent). Bis(2-hydroxyethyl)(p-methylsulfonylphenacyl)sulfonium tetrafluroborate and bis(2-hydroxyethyl)(p-methylsulfonylphenacyl)sulfonium triflate are compounds of formula (2) in claims 1 and 4, wherein Z- is an anion, m=1, n=2, R2 is a substituted alkyl group, R3 and R4 are hydrogen atoms, Ar is a divalent aromatic ring, l=1, and R1 is a *-L-R5, L is -SO2-, R5 is a methyl group (monovalent substituent). Therefore, the radiation-sensitive composition of Mertesdorf modified by Toba is equivalent to the radiation-sensitive composition in claims 1 and 4 of the instant application. With regard to claims 5-7, the 4-(1-methoxy-1-methylethoxy)styrene repeating unit is a repeating unit comprising a group decomposed by an action of an acid to generate a polar group, wherein the polar group is a phenolic hydroxyl group. The 4-(1-methoxy-1-methylethoxy)styrene repeating unit is a repeating unit of formula (6) in claims 6 and 7, wherein R22-R24 are hydrogen atoms, R25-R27 are alkyl groups with 1 carbon atom. With regard to claim 8, Mertesdorf et al. teach a resist film formed from the radiation-sensitive composition (par.0057). With regard to claims 9 and 10, Mertesdorf et al. teach a process comprising the steps of: -coating the radiation-sensitive composition onto a substrate and drying to form a resist film; -exposing the resist film to radiation; and -developing the resist film (par.0053-0061). The resist pattern may be used for microelectronics, printed circuits (par.0055, par.0065). Response to Arguments Applicant’s arguments with respect to claims 1 and 4-10 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. The examiner would like to note that: -the objection to the drawings is withdrawn after the filing of the replacement drawings; -the objection to the specification is withdrawn after the applicant’s amendment to par.0010 and par.0280; -the rejection of claims 1, 3-10, 19, and 20 under 35 U.S.C. 102(a)(1) as being anticipated by Miyoshi et al. (WO 2020/045534, with citations from the English equivalent US 2021/0165325) is withdrawn after the applicant’s amendments to claim 1; -the rejection of claims 1, 3-6, 8-10, 19, and 20 under 35 U.S.C. 102(a)(1) as being anticipated by Tsubaki et al. (US 2019/0219921) is withdrawn after the applicant’s amendment to claim 1; -the rejection of claims 1, 2, 5-10, and 13-18 under 35 U.S.C. 103 as being unpatentable over Takahashi et al. (JP 2004-279576A, with machine translation made of record on April 21, 2026) in view of Sooriyakumaran et al. (US 2002/0081520) or Urano et al. (US Patent 5,558,976) is withdrawn after the applicant’s amendment to claim 1; and -the rejection of claims 1-3, 5-11, 13, 14, and 16-20 under 35 U.S.C. 103 as being unpatentable over Kodama et al. (US 2005/0019689), as evidenced by Smyj et al. (US 2005/0137401) is withdrawn after the applicant’s amendment to claim 1. However, new grounds of rejection for claims 1 and 4-10 are shown in paragraphs 5-6 above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANCA EOFF whose telephone number is (571)272-9810. The examiner can normally be reached Mon-Fri 10am-6:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niki Bakhtiari can be reached at (571)272-3433. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANCA EOFF/Primary Examiner, Art Unit 1722
Read full office action

Prosecution Timeline

Aug 30, 2023
Application Filed
Apr 21, 2026
Non-Final Rejection mailed — §103
Jul 17, 2026
Response Filed
Aug 06, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12736879
Bismaleimide Compound, Composition Containing Same, Polybenzoxazole, And Semiconductor Device
3y 7m to grant Granted Sep 15, 2026
Patent 12731864
LITHIUM BATTERY AND MANUFACTURING METHOD THEREFOR
3y 2m to grant Granted Sep 08, 2026
Patent 12731861
SEPARATOR FOR ELECTROCHEMICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME
3y 6m to grant Granted Sep 08, 2026
Patent 12731858
OXIDIZED BACTERIAL CELLULOSE SEPARATOR FOR BATTERIES AND METHOD FOR PRODUCING THE SAME
3y 8m to grant Granted Sep 08, 2026
Patent 12725829
CROSS-LINKED SOLID-POLYMER ELECTROLYTES, METHODS OF MAKING SAME, AND USES THEREOF
4y 0m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
80%
Grant Probability
91%
With Interview (+10.8%)
2y 8m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1256 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month